Related Experiment Videos
Acute biphenotypic leukaemia: immunophenotypic and cytogenetic analysis
C A Hanson1, M Abaza, S Sheldon
1Department of Pathology, University of Michigan Hospitals, Ann Arbor.
British Journal of Haematology
|May 1, 1993
Summary
Diagnosing acute biphenotypic leukaemia is challenging due to inconsistent criteria, leading to varied reported incidences. This study proposes strict diagnostic standards for better classification of this complex leukemia.
Area of Science:
- Hematology
- Oncology
- Immunophenotyping
Background:
- Reported incidence of acute biphenotypic leukaemia varies widely (1% to 50%).
- Variability attributed to inconsistent diagnostic criteria, antibody panels, and lack of lineage specificity.
- Need for standardized diagnostic approaches in acute leukaemias.
Purpose of the Study:
- To investigate the morphology, cytochemistry, immunophenotype, and cytogenetics of acute biphenotypic leukaemias.
- To establish consistent diagnostic criteria for acute biphenotypic leukaemia.
- To explore immunophenotypic and cytogenetic subgroups within acute biphenotypic leukaemia.
Main Methods:
- Analysis of morphology, light scatter, and antibody fluorescence histograms.
- Application of strict diagnostic criteria considering cell morphology and marker expression.
- Immunophenotyping and chromosomal analysis of 746 acute leukaemia cases.
Main Results:
- 7% (52/746) of cases met the criteria for acute biphenotypic leukaemia.
- Subgroups included acute lymphoblastic leukaemia (ALL) with myeloid antigens (30), acute myelogenous leukaemia (AML) with lymphoid markers (21), and mixed B-/T-cell ALL (1).
- Clonal chromosomal abnormalities found in 31 of 42 analyzed cases.
Conclusions:
- Strict, uniform diagnostic criteria are essential for consistent diagnosis of acute biphenotypic leukaemia.
- Acute biphenotypic leukaemia comprises biologically distinct subgroups based on immunophenotype and cytogenetics.
- Standardized diagnosis can help resolve discrepancies in reported incidence rates.